Key facts
- ZILA BioWorks’s last known valuation is $7.9M (Apr 2024).
- It has raised $4.0M; the latest was Later Stage VC ($600K) in Feb 2026.
- Notable investors include E8 (Seattle), JEC Composites Startup Booster, Natural Products Canada, Keeler Investments Group, Big Red Ventures — 18 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 18 names
- ·Watchlist + deal alerts for ZILA BioWorks
- ·The full record, as it builds
Funding rounds
No funding rounds for ZILA BioWorks are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ZILA BioWorks
Developer of a bio-based epoxy resin designed to lower environmental impact while maintaining performance in industrial materials. The company offers a high bio-content epoxy resin suitable for composites, coatings, and adhesives, enabling manufacturers of industrial and outdoor products to reduce carbon impact and improve material recyclability without compromising durability.
- Sector
- Materials and Resources
- HQ
- Renton, WA, United States
- Founded
- 2014
- Employees
- 5
- Website
- zilabioworks.com/
- Ownership
- Privately Held (backing)
ZILA BioWorks doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ZILA BioWorks shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ZILA BioWorks in its N-PORT filings yet. We sweep new filings monthly.